Initial Blood Work for Suspected Pituitary Adenoma
All patients with suspected pituitary adenoma require comprehensive anterior pituitary axis testing including prolactin, IGF-1, thyroid function, adrenal function, and gonadal hormones to assess for both hormone hypersecretion and hypopituitarism. 1
Essential Hormone Testing
Assess for Hormone Hypersecretion
Prolactin (PRL): Mandatory in all patients to rule out prolactinoma, which may not be clinically suspected and accounts for 32-66% of pituitary adenomas 1, 2
Insulin-like Growth Factor 1 (IGF-1): Recommended to detect clinically silent growth hormone-secreting tumors, as up to 46% of apparently nonfunctioning adenomas show GH immunostaining despite lack of clinical acromegaly 1
24-hour urinary free cortisol or late-night salivary cortisol: Screen for ACTH-secreting tumors causing Cushing's disease 3, 2
TSH with free T4 and free T3: Evaluate for rare TSH-secreting adenomas (1% of cases) 3, 2
Assess for Hypopituitarism
The prevalence of hypopituitarism in pituitary adenomas is substantial, with deficiencies often exceeding clinical suspicion 1:
Thyroid axis: TSH and free T4 to detect central hypothyroidism (present in 8-81% of patients) 1
Adrenal axis: Morning cortisol ± ACTH (adrenal insufficiency occurs in 17-62% of patients) 1
Gonadal axis:
- In women: LH, FSH, estradiol
- In men: LH, FSH, testosterone
- Hypogonadism is one of the most commonly affected axes 1
Growth hormone axis: While GH deficiency is common (most frequently affected axis), routine testing is complex and may be deferred to endocrinology 1
Critical Clinical Considerations
Preoperative hormone replacement is mandatory for patients with adrenal insufficiency and significant hypothyroidism before any surgical intervention. 1 The cutoff values for initiating thyroid and adrenal replacement differ in panhypopituitarism versus isolated deficiencies, making comprehensive testing essential 1.
Common Pitfalls to Avoid
Do not assume normal function based on clinical presentation alone: Hormone deficiencies frequently exceed clinical suspicion across all pituitary axes 1
Do not miss prolactinomas: Even modest prolactin elevations warrant attention, as dopamine agonists are first-line treatment rather than surgery 3, 2, 4
Do not overlook "stalk effect": Mild prolactin elevation (typically <200 ng/mL) may result from stalk compression by a nonfunctioning adenoma rather than a true prolactinoma 3
Coordinate with endocrinology early: Interpretation of pituitary hormone testing requires specialized expertise, particularly for dynamic testing that may be needed in selected cases 1, 3, 4